Immobilization mediated enhancement of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus
-
Add time:08/05/2019 Source:sciencedirect.com
ABSTRACTPhyllanthus amarus plant is used in the traditional system of medicine as a hepatoprotective drug for which the major lignans PHYLLANTHIN (cas 10351-88-9) and hypophyllanthin are responsible. So far, no significant work has been done on the culture of this plant. Realizing the hepatoprotective potential, the present investigation was undertaken. A cost effective process was developed for enhancing phyllanthin and hypophyllanthin utilizing the immobilization technique. HPTLC was used to compare the phyllanthin and hypophyllanthin contents in calcium alginate immobilized cells obtained from fresh grown plants and MS medium was supplemented with different abiotic elicitors, under aseptic conditions for the treatment with chitosan, copper sulphate, phenylalanine and silver nitrate solution to make the whole process commercially viable. It was revealed that silver nitrate and phenylalanine at low concentration enhances phyllanthin and hypophyllanthin yield as compared to control immobilized cell culture. The study revealed that an increase in the content of phyllanthin and hypophyllanthin was elicitor concentration dependent and silver nitrate treatment gave a maximum yield of hepatoprotective bioactives as compared to the other abiotic elicitors used.
We also recommend Trading Suppliers and Manufacturers of PHYLLANTHIN (cas 10351-88-9). Pls Click Website Link as below: cas 10351-88-9 suppliers
Prev:Determination of PHYLLANTHIN (cas 10351-88-9) and Gallic Acid In Herbal Hepatoprotective Formulation By TLC-Densitometry Analysis
Next:Investigation of anticancer potential of hypoPHYLLANTHIN (cas 10351-88-9) and PHYLLANTHIN (cas 10351-88-9) against breast cancer by in vitro and in vivo methods) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Investigation of anticancer potential of hypoPHYLLANTHIN (cas 10351-88-9) and PHYLLANTHIN (cas 10351-88-9) against breast cancer by in vitro and in vivo methods08/06/2019
- Determination of PHYLLANTHIN (cas 10351-88-9) and Gallic Acid In Herbal Hepatoprotective Formulation By TLC-Densitometry Analysis08/04/2019
- Endothelium-independent effects of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) on vascular tension08/03/2019
- Cytotoxic, caspase-3 induction and in vivo hepatoprotective effects of PHYLLANTHIN (cas 10351-88-9), a major constituent of Phyllanthus niruri08/02/2019
- Ameliorative effects of PHYLLANTHIN (cas 10351-88-9) on carbon tetrachloride-induced hepatic oxidative damage in mice08/01/2019
- PHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus inhibits cellular and humoral immune responses in Balb/C mice07/31/2019
- HPLC fingerprint and simultaneous quantitative analysis of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) for identification and authentication of Phyllanthus niruri from related species07/30/2019
- Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by PHYLLANTHIN (cas 10351-88-9)07/29/2019
- Preparation, toxicity analysis and in vivo protective effect of PHYLLANTHIN (cas 10351-88-9)-loaded PLGA nanoparticles against CCl4-induced hepatic fibrosis07/28/2019